105 related articles for article (PubMed ID: 24226956)
21. Interleukin 5 in the link between the innate and acquired immune response.
Takatsu K; Kouro T; Nagai Y
Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
[TBL] [Abstract][Full Text] [Related]
22. [The influence of C57B1/6J mice immunization by oxidized low-density lipoprotein on the intensity of atherosclerotic changes].
Arkh Patol; 2011; 73(4):38-41. PubMed ID: 22164430
[TBL] [Abstract][Full Text] [Related]
23. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
[TBL] [Abstract][Full Text] [Related]
24. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
25. Once Upon a Time: The Adaptive Immune Response in Atherosclerosis--a Fairy Tale No More.
Le Borgne M; Caligiuri G; Nicoletti A
Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S13-8. PubMed ID: 26605642
[TBL] [Abstract][Full Text] [Related]
26. Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.
Dietrich T; Hucko T; Schneemann C; Neumann M; Menrad A; Willuda J; Atrott K; Stibenz D; Fleck E; Graf K; Menssen HD
Atherosclerosis; 2012 Feb; 220(2):329-36. PubMed ID: 22062588
[TBL] [Abstract][Full Text] [Related]
27. Adaptive Response of T and B Cells in Atherosclerosis.
Ketelhuth DF; Hansson GK
Circ Res; 2016 Feb; 118(4):668-78. PubMed ID: 26892965
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
[TBL] [Abstract][Full Text] [Related]
29. Immunostaining of Lymphocytes in Mouse Atherosclerotic Plaque.
Gisterå A; Ketelhuth DF
Methods Mol Biol; 2015; 1339():149-59. PubMed ID: 26445787
[TBL] [Abstract][Full Text] [Related]
30. Evolutionary implication of B-1 lineage cells from innate to adaptive immunity.
Zhu LY; Shao T; Nie L; Zhu LY; Xiang LX; Shao JZ
Mol Immunol; 2016 Jan; 69():123-30. PubMed ID: 26573260
[TBL] [Abstract][Full Text] [Related]
31. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
[TBL] [Abstract][Full Text] [Related]
32. Immunostaining of Macrophages, Endothelial Cells, and Smooth Muscle Cells in the Atherosclerotic Mouse Aorta.
Menon P; Fisher EA
Methods Mol Biol; 2015; 1339():131-48. PubMed ID: 26445786
[TBL] [Abstract][Full Text] [Related]
33. Systematic Evaluation of the Cellular Innate Immune Response During the Process of Human Atherosclerosis.
van Dijk RA; Rijs K; Wezel A; Hamming JF; Kolodgie FD; Virmani R; Schaapherder AF; Lindeman JH
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27312803
[TBL] [Abstract][Full Text] [Related]
34. [The significance of anti-aortic heterologous antibodies in the development of experimental atherosclerosis].
Miagkaia IP
Vrach Delo; 1972 Jun; 6():75-9. PubMed ID: 5043616
[No Abstract] [Full Text] [Related]
35. 2019 Russell Ross Memorial Lecture in Vascular Biology: B Lymphocyte-Mediated Protective Immunity in Atherosclerosis.
Upadhye A; Sturek JM; McNamara CA
Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):309-322. PubMed ID: 31852222
[TBL] [Abstract][Full Text] [Related]
36. [Antigenic properties of human aorta in atherosclerosis].
Brusilovskiĭ ES; Grokhotova SG; Khendogina VT
Ter Arkh; 1972 Sep; 44(9):19-22. PubMed ID: 4660393
[No Abstract] [Full Text] [Related]
37. Interleukin-10 production and T cell-suppressive capacity in B cell subsets from atherosclerotic apoE
Rincón-Arévalo H; Villa-Pulgarín J; Tabares J; Rojas M; Vásquez G; Ramírez-Pineda JR; Castaño D; Yassin LM
Immunol Res; 2017 Oct; 65(5):995-1008. PubMed ID: 28744806
[TBL] [Abstract][Full Text] [Related]
38. Roles of B-1 and B-2 cells in innate and acquired IgA-mediated immunity.
Suzuki K; Maruya M; Kawamoto S; Fagarasan S
Immunol Rev; 2010 Sep; 237(1):180-90. PubMed ID: 20727036
[TBL] [Abstract][Full Text] [Related]
39. Air pollution and antibodies against modified lipoproteins are associated with atherosclerosis and vascular remodeling in hyperlipemic mice.
Soares SR; Carvalho-Oliveira R; Ramos-Sanchez E; Catanozi S; da Silva LF; Mauad T; Gidlund M; Goto H; Garcia ML
Atherosclerosis; 2009 Dec; 207(2):368-73. PubMed ID: 19486979
[TBL] [Abstract][Full Text] [Related]
40. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
